Showing posts with label AHA. Show all posts
Showing posts with label AHA. Show all posts

Tuesday, May 15, 2018

ACOG/AHA calls for including a ‘Heart-talk’ during the annual well-woman visit



A joint advisory issued by American College of Obstetrician and Gynecologists (ACOG) and American Heart Association(AHA) calls for all gynecologist to screen women for signs of cardiovascular disease and risk factors during their annual ‘well-woman’ visit.

The presidential advisory published 10 May in Journal Circulation calls for a collaboration between cardiologists and Ob/Gyn physicians to use these visits as an opportunity to screen, counsel and educate women about lifestyle factors that influence the risk of heart diseases.

This is important because, for more than 50% of women, their Ob/Gyn physician is the only primary care doctor they visit every year.

“OB/GYNs are primary care providers for many women, and the annual ‘well woman’ visit provides a powerful opportunity to counsel patients about achieving and maintaining a heart-healthy lifestyle, which is a cornerstone of maintaining heart health” said John Warner, M.D. president of the American Heart Association, executive vice president for Health System Affairs at University of Texas Southwestern Medical Center in Dallas, Texas.

Dr. Stacey Rosen, MD, a cardiologist, co-author of the advisory and vice president of The Katz Institute for Women's Health at Northwell Health said, "We know that 90 percent of women have at least one risk factor for heart disease and that 80 percent of heart disease is preventable through a heart-healthy lifestyle.”

A post-partum visit is an ideal opportunity to identify women with pregnancy complications like pre-eclampsia, eclampsia, chronic hypertension, gestational diabetes, gestational hypertension, pre-term delivery, and low-for-estimated-gestational-age birth weight which all indicate a subsequent increase in the mother’s cardiovascular risk.

Preeclampsia and gestational hypertension impart a three- to six-fold excess risk of subsequent hypertension and a two-fold risk for subsequent heart disease.

In 2001, the Institute of Medicine now the National Academy of Sciences, issued a monograph" Exploring the Biological Contributions to Human Health: Does Sex Matter?" This initiated research on gender-specific risk factors for chronic diseases and development of guidelines that are distinct for men and women based on their unique health risks.

This has considerably helped in bringing down the morbidity and mortality associated with cardiac disease in women in last two decades.

Despite this progress, gender-specific inequalities continue when it comes to managing risk factors for cardiac disease. For example, women who have diabetes are at increased risk of CVD as compared to men (19% vs 10%) but they are far less likely to receive preventive treatment as compared to men.

Similarly, only 29% of older women have a well-controlled blood pressure as compared to 41% of older men.

In women, the CVD risk factors are often related to hormonal or pregnancy influences, such as pregnancy complications and polycystic ovary syndrome, menopausal status and hormone use, but these are seldom considered when calculating the risk of CVD.

Some of the common recommendations in the advisory include:

  • All women should be weighed at every visit and diet assessment should be performed through a predetermined questionnaire.
  • Women are advised to perform 150 minutes per week of moderate-intensity physical activity, 75 minutes per week of vigorous-intensity aerobic physical activity or a combination of both levels. Women should also walk 10,000 steps per day.
  • Presence of behavioral risk factors like smoking and alcohol should be assessed.
  • Screening for Glucose intolerance should be done in women 40 to 70 years with obesity or overweight, a history of gestational diabetes, a family history of diabetes or established CVD.
  • All women above 20 years of age with a family history of CVD, should undergo lipid screening. Lifestyle modification followed by statins is advised in those with elevated lipids.
  • Women with family history of CVD should also be screened for blood pressure every 2 years and annually after 40 years of age.
  • Medical therapy would be considered for women without CVD or elevated risk for the disease and with BP measurements greater than 140 mm Hg/90 mm Hg.
  • Ob/Gyn and cardiologist should make sure that patients Electronic Health Record (EHR) is complete during each visit and is something does not look good, patients should be referred to a specialist.
The clinicians and patients can visit the following websites to get patient education material.


Here is one video from  AHA series ' Life's Simple 7'




Monday, November 13, 2017

The American Heart Association updates BP guidelines in 14 years: now 130 is the new 140


The American Heart Association (AHA)  and The American College of Cardiology (ACC) has changed the definition of hypertension for the first time in 14 years, moving the number from the old standard of 140/90 to the newly revised 130/80.

According to the new definition, 130 to 139 mm Hg systolic and or 80 to 89 mm Hg will be labelled as stage 1 hypertension.

The guidelines were released here at the American Heart Association(AHA) 2017 Scientific Sessions : November 11–15, 2017, Anaheim, California and published simultaneously in the Journal of the American College of Cardiology,and in the AHA journal Hypertension.

The definition of the normal blood pressure has not changed in the new classification , but the new guidelines eliminate the class of ‘ pre-hypertension’.

Previously a systolic pressure between 120 and 129 and diastolic pressure less than 80 mm Hg was classified as pre-hypertension, now it is defined as elevated BP and a systolic pressure 130 to 139 or a diastolic pressure of 80 to 89 mm Hg is labelled as stage 1 hypertension.



This new classification raises the prevalence of hypertension from 31.9% to 45.6% and number of Americans with hypertension from 72.2 to 103.3 million.

In patients who are labelled as stage 1 hypertension, the treatment will be guided by underlying cardiovascular risk: only those with clinical cardiovascular disease or an estimated risk of 10% or more of atherosclerotic cardiovascular disease (ASCVD) would be offered treatment, and the remainder should be given advice on lifestyle modification.

Dr Robert M Carey (University of Virginia School of Medicine), Vice-chair of the writing committee said in a briefing, "Lifestyle modification is the cornerstone of the treatment of hypertension, and we expect that this guideline will cause our society and our physician community to really pay attention much more to lifestyle recommendations."

Specific recommendations include advice to lose weight, follow a DASH-pattern diet, reduce sodium to less than 1500 mg/day and increase potassium intake to 3500 mg/day through dietary intake, increase physical activity to a minimum of 30 minutes of exercise three times per week, and limit alcohol intake to two drinks or less per day for men and one or less for women.

The new goals of treating hypertension has also decreased since the last guideline, lowering it  from 140/90 mm Hg  to a target of 130/80 mm Hg.

The guidelines were developed after a thorough and systematic scientific review of over 900 publications over 3 years and felt that lowering the BP limit will improve the cardiovascular health of all Americans.

The notable studies were  SPRINT and ACCORD trials, in which lowering the blood pressure reduced CVD morbidity and mortality without any increased risk for falls or orthostatic hypotension.

New release by AHA
Full text PDF in Journal Hypertension 

                     Understanding the 2017 Hypertension Guidelines





Tuesday, January 17, 2017

American Heart Association updates guidelines on Managing Pregnancy in CHD Patients.

Courtesy: http://www.heartdiseaseandpregnancy.com/

AHA


With advances in surgery and medical management, more and more female children born with CHD are reaching reproductive age. The most recent statistics by AHA  estimates that 1 in 150  adults have some form of CHD.

Ability to successfully carry the pregnancy to term, intrapartum and postpartum management of these patients involve multidisciplinary coordination and monitoring.  It includes a cardiologist expert in treating CHD, a maternal-fetal medicine  specialist, heart anesthesiologists and heart surgeons. 

“Women with complex congenital heart disease were previously advised to not get pregnant because of the risk to their life,” said Mary M. Canobbio, R.N., M.N., chair of the writing committee for the new scientific statement published in the American Heart Association Journal Circulation.[1]

“Now scientific research demonstrates that with proper management in the hands of experienced cardiologists and obstetricians, these women can have successful pregnancies,” said Canobbio, who is also a lecturer at UCLA School of Nursing in Los Angeles, California.[2]


courtesy: American Heart Association.


Most common complex defects seen in practice are single ventricle, transposition of great arteries, pulmonary hypertension and aortic valve stenosis.

In pregnancy, the blood volume increases by 40%, cardiac output increases by 30-50% with heart rate increasing by 10-20 beats/min. This change in circulation dynamic is very taxing to the heart.[3] The physician needs to assess beforehand whether the heart can handle this increased load.

The strategy to manage patients with complex CHD with pregnancy begins by preconception counselling and assessing the risk to mother and fetus, which includes genetic counselling as the risk of recurrence of CHD is always real.  The clinician should assess the volume overload, tachycardia and hypercoagulable state along with the need for constant medications.

The second most important issue is the management during pregnancy, which includes the diagnostic test required, medication alteration if teratogenic and fetal screening beside the routine antenatal care in pregnancy. Blood thinners are known to be harmful to the fetus.

Low risk patients are seen by cardiologist in first and last trimester while moderate to high risk patients are evaluated each trimester at a tertiary care center by a maternal-fetal medicine specialist. Fetal echocardiography at 18-22 weeks is recommended for all patients.

Intrapartum care, access to a tertiary care center, insurance and availability of cardiologist at the time of delivery should be discussed with the patients. Each patient should have an individual plan for her delivery, according to her medical needs. Experts advice use of narcotics and epidural to limit the urge to 'push' which increases load on heart. 

Postpartum the patients should be closely monitored in a cardiac intensive care unit and monitored for volume overload in the first 24-48 hours. In some patient close monitoring is needed for 6 months because of residual effects of pregnancy.

This scientific statement also stress the need for developing and collecting data on large cohorts of patients so that preconception care outline and pregnancy complication stratified according to individual congenital malformation can be known.

“This scientific statement outlines the specific management for these high-risk patients,” Canobbio said. “What we know about the risks for these patients, what the potential complications are, what cardiologists, advanced practice nurses and other cardiac health providers should discuss in counseling these women, and once pregnant, recommendations in terms of the things we should be looking out for when caring these women.”

Full text of the article can be found here.





[1] http://circ.ahajournals.org/content/early/2017/01/12/CIR.0000000000000458
[2] http://newsroom.heart.org/news/women-with-high-risk-congenital-heart-disease-can-have-successful-pregnancies
[3] http://news.heart.org/successful-pregnancy-possible-for-some-women-with-high-risk-congenital-heart-disease-2/?utm_campaign=sciencenews16-17&utm_source=science-news&utm_medium=phd-link&utm_content=phd01-12-16